BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31473564)

  • 1. Comparative efficacy and acceptability of first-line drugs for the acute treatment of generalized anxiety disorder in adults: A network meta-analysis.
    He H; Xiang Y; Gao F; Bai L; Gao F; Fan Y; Lyu J; Ma X
    J Psychiatr Res; 2019 Nov; 118():21-30. PubMed ID: 31473564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
    Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
    Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis.
    Slee A; Nazareth I; Bondaronek P; Liu Y; Cheng Z; Freemantle N
    Lancet; 2019 Feb; 393(10173):768-777. PubMed ID: 30712879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Remission Rates and Tolerability of Drugs for Generalised Anxiety Disorder: A Systematic Review and Network Meta-analysis of Double-Blind Randomized Controlled Trials.
    Kong W; Deng H; Wan J; Zhou Y; Zhou Y; Song B; Wang X
    Front Pharmacol; 2020; 11():580858. PubMed ID: 33343351
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of drug treatments for generalised anxiety disorder: systematic review and meta-analysis.
    Baldwin D; Woods R; Lawson R; Taylor D
    BMJ; 2011 Mar; 342():d1199. PubMed ID: 21398351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicinal herbs for the treatment of anxiety: A systematic review and network meta-analysis.
    Zhang W; Yan Y; Wu Y; Yang H; Zhu P; Yan F; Zhao R; Tian P; Wang T; Fan Q; Su Z
    Pharmacol Res; 2022 May; 179():106204. PubMed ID: 35378276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of vilazodone for the acute treatment of generalized anxiety disorder: A meta-analysis.
    Zareifopoulos N; Dylja I
    Asian J Psychiatr; 2017 Apr; 26():115-122. PubMed ID: 28483071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vortioxetine, a multimodal antidepressant for generalized anxiety disorder: a systematic review and meta-analysis.
    Pae CU; Wang SM; Han C; Lee SJ; Patkar AA; Masand PS; Serretti A
    J Psychiatr Res; 2015 May; 64():88-98. PubMed ID: 25851751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and Safety of Vilazodone in Patients With Generalized Anxiety Disorder: A Randomized, Double-Blind, Placebo-Controlled, Flexible-Dose Trial.
    Durgam S; Gommoll C; Forero G; Nunez R; Tang X; Mathews M; Sheehan DV
    J Clin Psychiatry; 2016 Dec; 77(12):1687-1694. PubMed ID: 27232052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
    Cipriani A; Zhou X; Del Giovane C; Hetrick SE; Qin B; Whittington C; Coghill D; Zhang Y; Hazell P; Leucht S; Cuijpers P; Pu J; Cohen D; Ravindran AV; Liu Y; Michael KD; Yang L; Liu L; Xie P
    Lancet; 2016 Aug; 388(10047):881-90. PubMed ID: 27289172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised, double-blind, placebo-controlled, duloxetine-referenced study of the efficacy and tolerability of vortioxetine in the acute treatment of adults with generalised anxiety disorder.
    Mahableshwarkar AR; Jacobsen PL; Chen Y; Simon JS
    Int J Clin Pract; 2014 Jan; 68(1):49-59. PubMed ID: 24341301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of short-term duloxetine treatment in adults with generalized anxiety disorder: A meta-analysis.
    Li X; Zhu L; Zhou C; Liu J; Du H; Wang C; Fang S
    PLoS One; 2018; 13(3):e0194501. PubMed ID: 29558528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duloxetine in treating generalized anxiety disorder in adults: A meta-analysis of published randomized, double-blind, placebo-controlled trials.
    Zhang Y; Huang G; Yang S; Liang W; Zhang L; Wang C
    Asia Pac Psychiatry; 2016 Sep; 8(3):215-25. PubMed ID: 26238298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of levomilnacipran, vilazodone and vortioxetine compared with other second-generation antidepressants for major depressive disorder in adults: A systematic review and network meta-analysis.
    Wagner G; Schultes MT; Titscher V; Teufer B; Klerings I; Gartlehner G
    J Affect Disord; 2018 Mar; 228():1-12. PubMed ID: 29197738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, fixed-dose study comparing the efficacy and tolerability of vortioxetine 2.5 and 10 mg in acute treatment of adults with generalized anxiety disorder.
    Mahableshwarkar AR; Jacobsen PL; Serenko M; Chen Y
    Hum Psychopharmacol; 2014 Jan; 29(1):64-72. PubMed ID: 24424707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vortioxetine treatment for generalised anxiety disorder: a meta-analysis of anxiety, quality of life and safety outcomes.
    Qin B; Huang G; Yang Q; Zhao M; Chen H; Gao W; Yang M
    BMJ Open; 2019 Nov; 9(11):e033161. PubMed ID: 31784448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative Efficacy and Acceptability of Antidepressant Drugs in Adults With Major Depressive Disorder: Commentary on a Network Meta-Analysis.
    Andrade C
    J Clin Psychiatry; 2018; 79(2):. PubMed ID: 29718600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and Tolerability of Pharmacotherapy for Pediatric Anxiety Disorders: A Network Meta-Analysis.
    Dobson ET; Bloch MH; Strawn JR
    J Clin Psychiatry; 2019 Jan; 80(1):. PubMed ID: 30753760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyzine for generalised anxiety disorder.
    Guaiana G; Barbui C; Cipriani A
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006815. PubMed ID: 21154375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vortioxetine (Lu AA21004) in generalized anxiety disorder: results of an 8-week, multinational, randomized, double-blind, placebo-controlled clinical trial.
    Bidzan L; Mahableshwarkar AR; Jacobsen P; Yan M; Sheehan DV
    Eur Neuropsychopharmacol; 2012 Dec; 22(12):847-57. PubMed ID: 22898365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.